1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Ear Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Inoue, H; Koshihara, Y; Nagata, N | 1 |
| Forn, J; García-Rafanell, J; Giral, M; Gómez, LA; Merlos, M; Vericat, ML | 1 |
2 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Ear Diseases
| Article | Year |
|---|---|
Inhibition by actinomycin D of neurogenic mouse ear oedema.
Topics: Animals; Bradykinin; Calcimycin; Calcitonin Gene-Related Peptide; Capsaicin; Cycloheximide; Dactinomycin; Disease Models, Animal; Dose-Response Relationship, Drug; Doxorubicin; Ear Diseases; Edema; Histamine; Injections, Intravenous; Leukotriene C4; Male; Mast Cells; Mice; p-Methoxy-N-methylphenethylamine; Platelet Activating Factor; Rats; Rats, Wistar; Serotonin; Substance P; Tachykinins; Vasoactive Intestinal Peptide | 1995 |
Effects of PAF-antagonists in mouse ear oedema induced by several inflammatory agents.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Pressure; Ear Diseases; Ear, External; Edema; In Vitro Techniques; Lipoxygenase Inhibitors; Male; Mice; Platelet Activating Factor; Platelet Aggregation; Rabbits; Rats; Rats, Inbred Strains | 1991 |